FRACZOL

Zoledronic Acid Injection IP 4mg

Description

Zoledronic acid is a potent inhibitor of bone resorption. It
inhibits osteoclast proliferation and induces osteoclast
apoptotic cell death. Its potency results from its high affinity
for mineralized bone and especially for sites of high bone
turnover.

Additional information

INDICATION

– Hypercalcemia of malignancy
– Multiple myeloma and bone metastases of solid tumors
– Paget's disease
– Osteoporosis